Sophie Wang to Moderate Biologics and Biosimilars Panel at Patent Litigation Summit

Sophie Wang will moderate the panel, "Navigating the Complexities of BPCIA Litigation in the Biologics and Biosimilars Landscape" at the North America Pharma & Biotech Patent Litigation Summit on Tuesday, October 29th at 2:00 p.m.

The panel will discuss critical aspects of biologics and biosimilars litigation and provide valuable insights for effective litigation strategies, including:

• Understanding recent USPTO guidance on obviousness and its impact on filing and litigation strategies.
• Comparing and contrasting applications seeking resolution over prior art via PTAB proceedings.
• Determining the optimal timing for applicants to file IPR petitions relative to filing BLAs and initiating BPCIA litigation.

More information about the event can be found here.